Treg02

DRUG2 trials

Sponsors

Charite Universitaetsmedizin Berlin KöR

Conditions

Solid organ transplantation (Kidney)Solid organ transplantation (Liver)

Phase 1

A Phase I/IIa open label single ascending dose study to investigate the safety and tolerability of regulatory T cells as an adjunctive therapy in deceased-donor kidney recipients - ProTreg

RecruitingCTIS2024-514398-23-00

Charite Universitaetsmedizin Berlin KöRSolid organ transplantation (Kidney)

Start: 2024-06-10Target: 27Updated: 2025-09-10

A Phase I/IIa open label single ascending dose study to assess safety and tolerability of regulatory T cells to promote discontinuation of tacrolimus monotherapy in liver transplant recipients - LiveTreg

RecruitingCTIS2023-508261-32-00

Charite Universitaetsmedizin Berlin KöRSolid organ transplantation (Liver)

Start: 2025-07-21Target: 27Updated: 2025-08-14